Open-label RCT in 105 participants with gestational diabetes: real-time CGM vs blinded CGM plus SMBG gave similar time in range (93.0% vs 93.7%, p=.86); 31 of 52 SMBG participants withdrew, and insulin/metformin use was higher with RT-CGM (66.7% vs 33.4%).
RCTn = 105
Ehrhardt et al. A randomized controlled trial of real-time continuous glucose monitoring (RT-CGM) for self-management of gestational diabetes